- GlobeNewswire•9 days ago
-Plans to Initiate Phase 2 Study in Bulimia Nervosa-. -Company to Pursue Uplisting to a Major Stock Exchange-. SANTA MONICA, Calif., Jan. 11, 2017-- Opiant Pharmaceuticals, Inc., a specialty pharmaceutical ...
- The Wall Street Journal•10 days ago
The company also signed agreements with Intel and Accenture to provide its customers with more data and tools.
- GlobeNewswire•11 days agoOpiant Pharmaceuticals Featured in Recent Media Highlighting NARCAN® Nasal Spray and Heroin Vaccine Development
SANTA MONICA, Calif., Jan. 09, 2017-- Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders, was recently ...
OPNT : Summary for OPIANT PHARMACEUTI COM USD0.001 - Yahoo Finance
Opiant Pharmaceuticals, Inc. (OPNT)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||7.15 - 7.74|
|52 Week Range||5.01 - 8.89|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.89|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|